EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Advances in Syphilis Diagnostics to Address the 21st-Century Epidemic

Rebecca S Treger iD, Tim W Menza iD, Thao T Truong iD, Joshua A Lieberman iD

Clinical Chemistry · 03.09.2025 · 71 (9) · 935-948

DOI: 10.1093/clinchem/hvaf072 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Chemistry, online erschienen am 13.06.2025. Verfasst von Rebecca S Treger und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, University of Washington, School of Medicine, Seattle, WA, United States. Hauptthemen laut MEDLINE: Syphilis, Epidemics. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases, CDC HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background For 20 years, the United States has experienced a progressive rise in syphilis cases, increasing to >209 000 cases in 2023. The current case rate of 62.5 per 100 000 persons represents a 30-fold increase since 2000–2001, when a concerted national effort nearly eliminated the disease. This review highlights epidemiologic trends, current gold-standard diagnostic methods, emerging diagnostic tests, and key challenges for laboratorians. Content The current outbreak in the United States has been marked by dramatic increases in cases among women and men who have sex with women, resulting in 3800 congenital cases in 2023: a 10-fold rise over the last decade. Containing syphilis has been hampered by several factors. Recurrent shortages of the primary treatment, benzathine penicillin G, and a high prevalence of macrolide resistance have curtailed access to single-dose treatment options, necessitating multiday courses of doxycycline. The etiologic agent, Treponema pallidum subsp. pallidum, is a stealth pathogen with protean manifestations, thus posing a clinical challenge. Diagnostic testing, which has seen few updates in decades, has limited sensitivity in early or latent syphilis, and the need to integrate multiple serologic tests can delay turnaround times. Summary Public health interventions, such as doxycycline post-exposure prophylaxis, have started to contain the disease, and newer diagnostic tests may offer useful adjuncts for case finding. Serologic testing, with low cost and high sensitivity, is likely to remain the primary method for the screening and diagnosis of syphilis. Sustained investment in public health infrastructure and automation, interlaboratory data sharing, and addressing social determinants of health are critical to the reduction of syphilis cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SyphilisEpidemicsHumansTreponema pallidumFemaleMaleUnited StatesSyphilis SerodiagnosisAnti-Bacterial Agents

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, University of Washington, School of Medicine, Seattle, WA, United States.
  • Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, School of Medicine, Seattle, WA, United States.
  • Public Health -Seattle and King County, HIV/STI/HCV Program, Seattle, WA, United States.

ORCID-Profile: Rebecca S Treger, Tim W Menza, Thao T Truong, Joshua A Lieberman

Förderung

  • National Institute of Allergy and Infectious Diseases
  • CDC HHS
  • NIAID NIH HHS
  • HIV Prevention Services in Sexual Health Clinics
  • Centers for Disease Control and Prevention

Zitieren

APA

Treger, R. S., Menza, T. W., Truong, T. T., & Lieberman, J. A. (2025). Advances in Syphilis Diagnostics to Address the 21st-Century Epidemic. Clinical Chemistry, 71(9), 935-948. https://doi.org/10.1093/clinchem/hvaf072

Vancouver

Treger RS, Menza TW, Truong TT, Lieberman JA. Advances in Syphilis Diagnostics to Address the 21st-Century Epidemic. Clinical Chemistry. 2025;71(9):935-948. doi:10.1093/clinchem/hvaf072

BibTeX
@article{Treger2025,
  author = {Treger, Rebecca S and Menza, Tim W and Truong, Thao T and Lieberman, Joshua A},
  title = {Advances in Syphilis Diagnostics to Address the 21st-Century Epidemic},
  journal = {Clinical Chemistry},
  year = {2025},
  volume = {71},
  number = {9},
  pages = {935--948},
  doi = {10.1093/clinchem/hvaf072}
}
Kostenlos starten →